Abstract
With the advent of the COVID-19 pandemic, in-person social interactions and opportunities for accessing resources that sustain health and well-being have drastically reduced. We therefore designed the pan-Canadian population-based prospective COVID-19: HEalth and Social Inequities across Neighbourhoods (COHESION) cohort to provide deeper understanding of how the COVID-19 pandemic context affects mental health and well-being, key determinants of health, and health inequities.
This paper presents the design of the two-phase COHESION Study, and descriptive results from the first phase conducted between May 2020 and September 2021. During that period, the COHESION research platform collected monthly data linked to COVID-19 such as infection and vaccination status, perceptions and attitudes regarding pandemic-related measures, and information on participants’ physical and mental health, well-being, sleep, loneliness, resilience, substances use, living conditions, social interactions, activities, and mobility.
The 1,268 people enrolled in the Phase 1 COHESION Study are for the most part from Ontario (47%) and Quebec (33%), aged 48 ± 16 years [mean ± standard deviation (SD)], and mainly women (78%), White (85%), with a university degree (63%), and living in large urban centers (70%). According to the 298 ± 68 (mean ± SD) prospective questionnaires completed each month in average, the first year of follow-up reveals significant temporal variations in standardized indexes of well-being, loneliness, anxiety, depression, and psychological distress.
The COHESION Study will allow identifying trajectories of mental health and well-being while investigating their determinants and how these may vary by subgroup, over time, and across different provinces in Canada, in the unique context of the COVID-19 pandemic.
Competing Interest Statement
YK holds shares in Polygon Research Inc., the data collection platform that is used for the COHESION study. The content and views expressed in this article are those of the authors and do not necessarily reflect those of the Government of Canada
Funding Statement
The COHESION Study is supported by the Public Health Agency of Canada (PHAC, Ref # 4500416825 – 450041483, https://www.phac-aspc.gc.ca/) and the Fonds de Recherche du en Santé du Québec en Santé (FRQ-S, https://frq.gouv.qc.ca/sante/) and the Ministère de l’économie et de l’Innovation du Québec (Ref # 52266, Minist è re de l'économie et de l'Innovation - Québechttps://www.economie.gouv.qc.ca), and has benefited from infrastructure support from the Canadian Foundation for Innovation (CFI, Ref # 41072, https://www.innovation.ca/). The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Phase 1 COHESION was approved by the ethics board of the Centre de Recherche du Centre Hospitalier de l Universite de Montreal (CRCHUM; MP-02-2021-8924) and by the Public Health Agency of Canada (PHAC) ethical review board (REB 2020-016P). Phase 2 COHESION was approved by both the ethics board of the Centre Integre Universitaire de Sante et de Services Sociaux du Nord-de-l Ile-de-Montreal (CIUSSS-NIM ; 2022-2327) and PHAC (REB 2020-016P).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Abbreviations: COHESION: COVID-19: HEalth and Social Inequities across Neighbourhoods
The following disclaimer has been added: 'The content and views expressed in this article are those of the authors and do not necessarily reflect those of the Government of Canada'
Data Availability
All relevant data are within the manuscript and its Supporting Information files. A public dashboard is also available at: https://cohesionstudy.ca/dashboard/
